Description
Radioactive labeled molecules (radiopharmaceuticals, radiotracer) are used in nuclear medicine for the non-invasive diagnosis (imaging) and therapy of diseases. Different metallic and non-metallic radioactive isotopes of elements are available for radiotracer development. Gamma- (g) and positron- (b+) emitter are used for imaging by Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) respectively, whereas particle emitters (a, b-) are employed for internal radiation therapy. Radiometals offer the unique possibility to exchange a diagnostic by a therapeutic isotope, therefore enabling theranostic approaches. Examples of the development of radiometal-based radiopharmaceuticals specific for a molecular target important in oncology will be presented.Period | 11 Oct 2021 |
---|---|
Event title | Fakultätskolloquium der Fakultät für Chemie |
Event type | Lecture series, colloquium |
Location | Wien, AustriaShow on map |
Degree of Recognition | Regional |